Imp Manufacturing News Today

-- Represents the final step before submission of Investigational New Drug (IND) application to FDA, expected in the second half of 2023 --...

Forecyte Bio, CGT CDMO leader, officially opened its cGMP production suites for plasmid DNA, viral vector and cell therapy productions....

Aceto, a leading global provider of specialty materials for life sciences and advanced technology end markets, today reported it has consolidated and integrated its six manufacturing-related acquisitions to achieve a hybrid manufacturing/distribution model providing key benefits to its customers in high-growth end markets including pharmaceuticals, biopharmaceuticals, vaccines, nutraceuticals, agriculture, cosmetics and specialty chemicals.

Any doses. while you can say its just humanitarian, its also strategic. the variants im concerned about for our future vaccine success in this country are likely going to spin out of that uncontrolled transmission occurring in the low and middle income countries. weve got to try to do both. we need a manhattan project for p manufacturing. we need plans to get vaccines delivered throughout the world. >> i want to come back to the cases here in the united states right now. what you see coming in t...